Clinical Trial Update: Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 1/2 results for a combination of bortezomib (Velcade) with mitoxantrone and etoposide in relapsed or refractory acute l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Etoposide (Etoposide)
• Mitoxantrone (mitoxantrone)
• Velcade (bortezomib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Relapsed Acute Leukemia, Refractory Acute Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-04-17